Contents
Contents
Physician practice acquisition kickbacks put payment for future referrals into the price paid for a medical practice. The person negotiating the sale may see the proposed exchange before anyone submits a Medicare claim. A revised offer, a promise about where pathology work will go, and an agreement to use the buyer’s affiliated providers connect the sale price to the government money expected after closing.
Oliver Street Dermatology Management, doing business as U.S. Dermatology Partners, agreed to pay $8,892,079 in a September 2023 civil settlement over that alleged exchange. The Justice Department said former senior managers had offered or agreed to increase purchase prices for eleven acquired dermatology practices in return for referral agreements. Claims for certain referred services later went to Medicare. We see the problem in the alleged bargain: a bigger check for the seller in return for the physician’s future referrals. Patients became part of the price negotiation.
A kickback in a practice acquisition can be an increased purchase price offered in exchange for sending patients or services to the buyer’s affiliated providers. The Anti-Kickback Statute bars offering or paying money to induce referrals covered by Medicare and other federal health care programs. In this setting, the proposed benefit reaches the seller through the acquisition payment, while the expected return reaches another business through later medical orders.
The Stark Law addresses the financial relationship between a referring physician and the entity billing for certain referred services. In its Oliver Street announcement, the Justice Department said the alleged arrangements implicated both laws and led to false Medicare claims. The purchase negotiation and the later bill were parts of the same government allegation.
That puts a deal-team member in a different position from someone who sees only the bill. The bill identifies the service and the entity seeking payment. The negotiation may explain why the physician agreed to send the work there in the first place.
A revised offer can show what the seller was asked to promise in return for a higher price. With an acquisition insider, we connect valuation drafts and negotiations to the referral commitment and the government claims that followed.
Oliver Street manages and operates dermatology practices, surgical centers and pathology laboratories across the country. According to the government’s account of its settlement agreement, the acquisitions occurred from January 2013 through July 2018. The alleged bargain concerned services directed to U.S. Dermatology Partners’ affiliated entities after acquisition.
The allegation reached the offer or agreement to raise the price for a referral commitment. Someone who took part in those conversations may understand a change that the final price alone cannot explain.
A valuation analyst may know which assumptions changed between drafts. A practice manager may know when instructions about laboratory referrals changed. An employee working with orders or billing may see which affiliated entity began receiving the business.
The American Medical Association’s practice survey records physicians citing payer negotiations, access to costly resources, administrative requirements, additional services and competition for employees as reasons their practices sold. They give us something specific to compare with a buyer’s explanation for increasing an offer.
Acquisition platforms can centralize administration and billing, negotiate reimbursement and add ancillary services as they acquire smaller practices. When an offer rises in return for sending orders to an affiliated laboratory, the referral commitment belongs in the explanation of the price.
Calling part of a purchase price goodwill does not answer what the buyer expected in return. In the Oliver Street allegations, the exchange was a higher offered price for an agreement about future referrals. We care what the money bought, whatever the label.
A fair-market-value assessment and an examination of referral incentives address different parts of a financial arrangement. The 2020 Physician Leadership Journal article Proposed Stark Regulations: Small Step in the Right Direction explained that proposed Stark rules treated fair market value and the volume or value of referrals as separate questions, alongside a separate test of the arrangement’s business purpose.
For an acquisition insider, that distinction has a practical use. A report may describe how an analyst arrived at a price, while the negotiation shows what the buyer expected from the physician in return. A conclusion on the valuation’s cover cannot tell the whole story of a referral agreement negotiated elsewhere.
The government has challenged valuation inputs in other physician-payment cases. In the Community Health Network case, it alleged referral-linked compensation and misleading inputs provided for valuation work. That allegation makes the information supplied to an analyst worth examining alongside the resulting opinion.
Family Dermatology agreed to pay $3,247,835 in a 2015 civil settlement involving allegedly improper financial relationships with dermatologists and referrals to its in-house pathology laboratory. A physician’s complaint described both compensation and the money paid for practices as parts of the alleged inducement:
Defendants paid the referring independent contractor physicians substantial sums of money (in the form of a salary and the purchase money for their dermatology practice) to induce them to refer dermatopathology services
The physician also alleged that, shortly after signing the purchase and professional-services agreements, he was told to send all his pathology tests to a specified laboratory in Atlanta. The alleged instruction reached daily practice: every pathology test, one laboratory. The practice sale came with marching orders.
The same complaint described a proposed purchase funded through a loan from the selling physician to Family Dermatology, repayable over four years. That alleged arrangement put the buyer’s payment obligation in the transaction documents alongside the physician’s continuing professional relationship. The amount promised, the terms for paying it and the destination of future pathology work all belonged to the physician’s account of the proposed deal.
For a person handling acquisition records, the purchase terms and continuing service agreement may tell the story together. The complaint places the alleged referral demand alongside both the practice sale and a continuing payment obligation.
Post-acquisition orders connect a referral commitment to the service sent to the affiliated provider, and claims connect that service to government payment. In Oliver Street, the Justice Department said that claims for certain referred services were later submitted to Medicare. That connection takes the inquiry from money exchanged between buyer and seller to money requested from taxpayers.
Oliver Street’s business put dermatology practices, surgical centers and pathology laboratories under the same management company. Its alleged purchase-price bargains concerned referrals to affiliated entities, so the negotiation mattered beyond the practice being sold. A promise made at closing could determine where later work went and which provider billed Medicare.
Patients rely on medical judgment about where their specimens go, while the alleged bargain promised money to the seller for directing those services. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
Acquisition diligence can show what an investor learned about referral arrangements before becoming involved in a business. In a separate case involving Alliance Family of Companies, the Justice Department alleged that free EEG interpretation reports enabled referring physicians to bill as if they had performed the interpretations. It also alleged that investor Ancor Holdings learned of the kickbacks during diligence and allowed them to continue through its management role. The civil settlement announcement addressed both companies.
In the Ancor allegation, diligence brought knowledge of the kickbacks, and management supplied the means to let them continue. For an acquisition insider, that makes what the deal team knew as important as what it agreed to pay.
According to the Justice Department, Oliver Street disclosed that it had found credible evidence suggesting the purchase-price arrangements involving its former managers. The disclosure identified the transactions, personnel and potential financial impact. The government said the conduct had been unknown to it before the company disclosed it.
The U.S. Attorney’s Office for the Northern District of Texas and the U.S. Department of Health and Human Services’ Office of Inspector General coordinated the resolution. The company’s disclosure connected specific transactions and people to the potential cost to government, the same connections an acquisition insider may understand from inside the deal.
If you worked on a practice sale and know how referral commitments affected the price, speak with our whistleblower experts about the deal. We work beside you to connect the negotiation, the payments and the Medicare claims, and bring in healthcare fraud whistleblower lawyers who understand physician-practice acquisitions. Tell us what changed in the offer and what the seller was asked to promise.